医科院肿瘤医院冯奉仪教授：易瑞沙的发展历程.pptVIP

* * * * * * 60 % + ve for mutation out of 437 pts tested 437/683 64%could be evaluated for mut gene copy number interaction test: P = .0437 IHCP=0.21 * * * * * The time to event was calculated from the date of first dose to the earliest date of the following events occurring on randomised treatment; CTC grade 3 or 4 AE, worsening from baseline in any laboratory parameter to a CTC grade 3?or 4, or death. * The US IDEAL 2 study recruited a difficult to treat patient population – refractory symptomatic patients who had failed 2 or more previous chemotherapy regimens The rest of world (inclu